Quaero Capital S.A. I Mab Transaction History

Quaero Capital S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 11, 2022	SELL	$12.54 - $46.93 $955,033 - $3.57 Million	-76,159 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$47.86 - $83.95 $1.32 Million - $2.32 Million	27,669 Added 57.06%	76,159 $6.39 Million
Q1 2021 Apr 29, 2021	BUY	$44.38 - $63.97 $2.15 Million - $3.1 Million	48,490 New	48,490 $2.35 Million

16M

11.9K

3.5K

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $130M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

Get notified when there are updates to the investment portfolio of Quaero Capital S.A., based on Form 13F filings with the SEC.

Stay updated on Quaero Capital S.A. with notifications on news.